phenylbutazone sodium

Suppliers

Names

[ CAS No. ]:
129-18-0

[ Name ]:
phenylbutazone sodium

[Synonym ]:
PHENYLBUTAZONE SODIUM
3,5-dioxo-1,2-diphenyl-4-n-butylpyrazolidinsodium
4-BUTYL-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE SODIUM
Einecs 204-935-7
diphenyldioxobutylpyrazolidine-butazolidine-sodium
Phenylbutazone sodium salt
PHENYL BUTAZONE SODIUM SALT
sodiumphenylbutazone
MFCD01749404
Sodium 4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-ide
UNII:189M850I32
butazolidinesodium

Chemical & Physical Properties

[ Density]:
1.063 g/mL at 25 °C(lit.)

[ Boiling Point ]:
113 °C27 mm Hg(lit.)

[ Molecular Formula ]:
C19H19N2NaO2

[ Molecular Weight ]:
330.356

[ Flash Point ]:
95 °C

[ Exact Mass ]:
330.134430

[ PSA ]:
49.99000

[ LogP ]:
4.11460

[ Index of Refraction ]:
n20/D 1.516(lit.)

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UQ8300000
CHEMICAL NAME :
3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-, monosodium salt
CAS REGISTRY NUMBER :
129-18-0
LAST UPDATED :
199012
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C19-H20-N2-O2.Na
MOLECULAR WEIGHT :
331.40
WISWESSER LINE NOTATION :
T5VNNV EHJ BR& CR& E4 &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
16 mg/kg/D
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - structural or functional change in trachea or bronchi Blood - agranulocytosis Skin and Appendages - dermatitis, other (after systemic exposure)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
855 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
310 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
113 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
476 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
169 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
257 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
94 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
146 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
2160 umol/L
REFERENCE :
HUMAA7 Humangenetik. (Heidelberg, Fed. Rep. Ger.) V.1-30, 1964-75. For publisher information, see HUGEDQ. Volume(issue)/page/year: 12,330,1971

Safety Information

[ Hazard Codes ]:
C

[ Risk Phrases ]:
R36/37/38:Irritating to eyes, respiratory system and skin .

[ Safety Phrases ]:
S26-S36

[ HS Code ]:
2934100090

Customs

[ HS Code ]: 2934100090

[ Summary ]:
2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

Related Compounds

  • 4-butyl-1,2-diphenylpyrazolidine-3,5-dione,5-(cyclohepten-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione,4-(dimethylamino)-1,5-dimethyl-2-phenylpyrazol-3-one
  • Phenylbutazone(diphenyl-d10)
  • Phenylbutazone-d9
  • camp sodium salt
  • Aminonaphtylsulphonate sodium
  • 2-Hydroxy-2-propanesulfonic acid monosodium salt
  • {[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-oxo-2-(trifluoromethyl)-4H-chromen-7-yl]oxy}acetic acid
  • 3-{[(2-Methyl-5-oxo-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-yl)methyl]thio}propanoic acid
  • 4-[(3-Cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]piperidine
  • 2-(6-acetyl-2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetic acid
  • 2-Amino-3-[2-(2-chlorophenyl)-1,3-thiazol-4-yl]propanoic acid
  • 3-(3-Bromophenyl)-3-(5-methyl-1,3,4-oxadiazol-2-yl)propanoic acid
  • 8-fluoro-1H,2H,3H,4H,6H,7H,11bH-pyrazino[2,1-a]isoquinolin-4-one
  • 2-[4-(2-Fluorophenyl)phenyl]-2-methylpropanoic acid
  • Octahydropyrido[2,1-c]morpholin-3-ylmethanamine
  • tert-butyl N-[1-(aminooxy)propan-2-yl]carbamate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.